Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia

Treatment results for multiple myeloma and plasma cell leukemia have considerably improved, but cure remains elusive and establishing new therapeutic approaches constitutes a major unmet clinical need. We analyzed the anti-myeloma properties of the aza-anthracenedione pixantrone which has been succe...

Descripción completa

Detalles Bibliográficos
Autores principales: Willenbacher, Ella, Jöhrer, Karin, Willenbacher, Wolfgang, Flögel, Brigitte, Greil, Richard, Kircher, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848044/
https://www.ncbi.nlm.nih.gov/pubmed/31628518
http://dx.doi.org/10.1007/s00277-019-03797-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848044/
https://www.ncbi.nlm.nih.gov/pubmed/31628518
http://dx.doi.org/10.1007/s00277-019-03797-6

Ejemplares similares